16-3727696-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004380.3(CREBBP):​c.*22T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0182 in 1,613,564 control chromosomes in the GnomAD database, including 4,061 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.092 ( 2151 hom., cov: 31)
Exomes 𝑓: 0.010 ( 1910 hom. )

Consequence

CREBBP
NM_004380.3 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.0430

Publications

5 publications found
Variant links:
Genes affected
CREBBP (HGNC:2348): (CREB binding protein) This gene is ubiquitously expressed and is involved in the transcriptional coactivation of many different transcription factors. First isolated as a nuclear protein that binds to cAMP-response element binding protein (CREB), this gene is now known to play critical roles in embryonic development, growth control, and homeostasis by coupling chromatin remodeling to transcription factor recognition. The protein encoded by this gene has intrinsic histone acetyltransferase activity and also acts as a scaffold to stabilize additional protein interactions with the transcription complex. This protein acetylates both histone and non-histone proteins. This protein shares regions of very high sequence similarity with protein p300 in its bromodomain, cysteine-histidine-rich regions, and histone acetyltransferase domain. Mutations in this gene cause Rubinstein-Taybi syndrome (RTS). Chromosomal translocations involving this gene have been associated with acute myeloid leukemia. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2009]
CREBBP Gene-Disease associations (from GenCC):
  • Rubinstein-Taybi syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Illumina
  • Rubinstein-Taybi syndrome due to CREBBP mutations
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • Menke-Hennekam syndrome 1
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 16-3727696-A-G is Benign according to our data. Variant chr16-3727696-A-G is described in ClinVar as [Benign]. Clinvar id is 1230148.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.312 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CREBBPNM_004380.3 linkc.*22T>C 3_prime_UTR_variant Exon 31 of 31 ENST00000262367.10 NP_004371.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CREBBPENST00000262367.10 linkc.*22T>C 3_prime_UTR_variant Exon 31 of 31 1 NM_004380.3 ENSP00000262367.5 Q92793-1
CREBBPENST00000382070.7 linkc.*22T>C 3_prime_UTR_variant Exon 30 of 30 1 ENSP00000371502.3 Q92793-2

Frequencies

GnomAD3 genomes
AF:
0.0922
AC:
14004
AN:
151904
Hom.:
2135
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.316
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0422
Gnomad ASJ
AF:
0.0182
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00146
Gnomad FIN
AF:
0.0000943
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.00153
Gnomad OTH
AF:
0.0656
GnomAD2 exomes
AF:
0.0258
AC:
6473
AN:
251332
AF XY:
0.0187
show subpopulations
Gnomad AFR exome
AF:
0.332
Gnomad AMR exome
AF:
0.0194
Gnomad ASJ exome
AF:
0.0130
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00160
Gnomad OTH exome
AF:
0.0145
GnomAD4 exome
AF:
0.0104
AC:
15247
AN:
1461542
Hom.:
1910
Cov.:
32
AF XY:
0.00909
AC XY:
6608
AN XY:
727096
show subpopulations
African (AFR)
AF:
0.330
AC:
11042
AN:
33470
American (AMR)
AF:
0.0220
AC:
985
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.0151
AC:
394
AN:
26130
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.000835
AC:
72
AN:
86228
European-Finnish (FIN)
AF:
0.0000375
AC:
2
AN:
53282
Middle Eastern (MID)
AF:
0.0210
AC:
121
AN:
5766
European-Non Finnish (NFE)
AF:
0.00104
AC:
1161
AN:
1111864
Other (OTH)
AF:
0.0243
AC:
1470
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
635
1270
1906
2541
3176
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
332
664
996
1328
1660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0925
AC:
14062
AN:
152022
Hom.:
2151
Cov.:
31
AF XY:
0.0883
AC XY:
6566
AN XY:
74322
show subpopulations
African (AFR)
AF:
0.316
AC:
13102
AN:
41412
American (AMR)
AF:
0.0422
AC:
644
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.0182
AC:
63
AN:
3462
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5170
South Asian (SAS)
AF:
0.00146
AC:
7
AN:
4788
European-Finnish (FIN)
AF:
0.0000943
AC:
1
AN:
10610
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.00153
AC:
104
AN:
67992
Other (OTH)
AF:
0.0649
AC:
137
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
494
989
1483
1978
2472
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
128
256
384
512
640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0809
Hom.:
983
Bravo
AF:
0.107
Asia WGS
AF:
0.0240
AC:
85
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.69
CADD
Benign
6.8
DANN
Benign
0.69
PhyloP100
0.043
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2230140; hg19: chr16-3777697; API